| 2021 |
Shaymaa Hegazy (1st place) |
DNA mismatch repair deficient non-neoplastic endometrial glands are common in Lynch syndrome patients and present at higher density compared to colorectal mucosa |
| 2021 |
Simon Roy (2nd place) |
HPV-independent, p53 independent non-invasive verruciform lesions of the vulva: a comparison of clinical, histological and recurrence parameters |
| 2021 |
Lawrence Hsy Lin (2nd place) |
Small tumor nests are associated with poor clinical outcome in clear cell carcinoma of ovary |
| 2022 |
Felix Kommoss (1st place) |
Methylation Analysis Supports Classification of Endometrial Stromal Sarcomas with Variant BCOR and BCORL1 Alterations as High-Grade Endometrial Stromal Sarcomas |
| 2022 |
Janira Navarro (2nd place) |
Utility of a Comprehensive NGS 523-Gene Panel for the Simultaneous Analysis of Homologous Recombination Deficiency Score and Percent Genomic Loss of Heterozygosity Using a Cytogenetic Software Applied to the Evaluation of Epithelial Ovarian Tumors |
| 2022 |
Darin Dolezal (3rd place) |
Progressive microsatellite instability in recurrent MSI-H endometrial adenocarcinomas coincides with ARID1A frameshift and CTNNB1 mutations |
| 2023 |
Phoebe Hammer (1st place, shared) |
TCGA Molecular Subgroup Shows Greater Prognostic Significance Than Histologic Diagnosis in High-Grade Endometrial Carcinomas with Spindled, Undifferentiated and Sarcomatous Components |
| 2023 |
Neslihan Kayraklioglu (1st place, shared) |
High Tumor Mutational Burden Predicts Recurrence in Copy Number Low Early-Stage Endometrial Cancer and is Associated with ARID1A and TP53 Mutations |
| 2023 |
Xiaoming Zhang (2nd place) |
High-Grade Transformation of Ovarian Serous Borderline Tumors: A Series and Literature Review |
| 2024 |
Christopher Felicelli (1st place) |
Uterine Leiomyosarcoma Methylation Profiling Identifies Two Distinct Clusters With Unique Histologic and Clinical Behaviors |
| 2024 |
Emily Towery (2nd place) |
Fumarate Hydratase-Deficient Uterine Smooth Muscle Tumors: Description of 107 Cases Highlighting Their Diagnostic Spectrum and Expanding Recognized Patterns to Include Intravenous Leiomyomatosis and Disseminated Peritoneal Leiomyomatosis |
| 2024 |
Neslihan Kayraklioglu (3rd place) |
Endometrial Cancers with Low Level Microsatellite Instability: Classification Pitfalls and Practical Recommendations for Assigning Mismatch Repair Status by Next Generation Sequencing with MSIsensor and Ancillary Tests |
| 2025 |
Anusha Vemuri (1st place) |
A Deeper Dive into POLE-Mutated Endometrial Carcinomas: The Contributions and Consequences of Tumor Mutational Burden |
| 2025 |
Benjamin L. Coiner (2nd place, shared) |
CTNNB1-Mutant High Grade Endometrial Carcinoma: Clinical Outcomes and Prevalence of Pilomatrix-Like and Corded Hyalinized Morphologies in an Institutional Case Control Series |
| 2025 |
Haley N. Corbin (2nd place, shared) |
Spatial Architecture of Tumor-Infiltrating Lymphocytes Is an Independent Prognostic Marker in Vulvar Squamous Cell Carcinomas: A Multi-Institutional Assessment from the Lower Genital Tract Carcinoma Study Group |
| 2026 |
Blake Flood (1st place) |
Pathologic and Molecular Predictors of Immunotherapy Response In Endometrial Cancer Inform Outcomes Beyond TCGA Classification |
| 2026 |
Ramon Lorenzo D. Labitigan (2nd place) |
Distinguishing Primary Ovarian Carcinoid from Secondary Involvement by Extra-Ovarian Metastatic Neuroendocrine Tumor (NET) Using Short Tandem Repeat (STR) Genotype Testing to Assess for Loss of Heterozygosity (LOH) |
| 2026 |
Melissa Gildenberg (3rd place) |
When Endometrial Cancer Does Not Keep Its ProMisE: Benefits and Caveats of Universal Next Generation Sequencing for Molecular Classification |